Impaired neuronal plasticity in transgenic mice expressing human apolipoprotein E4 compared to E3 in a model of entorhinal cortex lesion

Neurobiology of Disease

Volumn 8, Issue 4, 2001, Pages 611-625

  White, F ^a   Horsburgh, K ^a   Nicoll, J A R ^a   Roses, A D ^b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Alzheimer s disease; Apolipoprotein E; Brain injury; Entorhinal cortex lesion; Sprouting; Synaptic degeneration; Transgenic mice

Indexed keywords

APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; ISOPROTEIN; NEUROMODULIN; SYNAPTOPHYSIN;

ALLELE; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN COMMISSURE; BRAIN INJURY; CONTROLLED STUDY; DENTATE GYRUS; DISEASE ASSOCIATION; DISEASE SEVERITY; ENTORHINAL CORTEX; FAMILIAL DISEASE; GENE INSERTION; GENOTYPE; GLIA CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LONG TERM CARE; MOUSE; NERVE CELL PLASTICITY; NEUROPIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE DIAGNOSIS; RETINA INNER PLEXIFORM LAYER; RISK FACTOR; TREATMENT OUTCOME;

EID: 0034864642     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1006/nbdi.2001.0401     Document Type: Article

References (63)

1. ApoE genotype and survival from intracerebral haemorrhage
2. Behavioural, physiological and morphological analysis of a line of apolipoprotein E knockout mouse
3. Plastic neuronal remodelling is impaired in patients with Alzheimer’s disease carrying apolipoprotein ε4 allele
4. The neurobiology of apolipoproteins and their receptors in the CNS and Alzheimer’s disease
5. Stable expression and secretion of apolipoproteins E3 and E4 in mouse neuroblastoma cells produces differential effects on neurite outgrowth
6. Association of apolipoprotein E genotype with brain levels of apolipoprotein E and apolipoprotein J (clusterin) in Alzheimer’s disease
7. Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system
8. −/ mice: Isoform specific effects on neurodegeneration
9. Dominant negative effects of apolipoprotein E4 revealed in transgenic models of neurodegenerative disease
10. Synaptic loss accompanied by an increase in synaptic area in the dentate gyrus of aged human apolipoprotein E4 transgenic mice
11. E4 allele dosage does not predict cholinergic activity or synapse loss in Alzheimer’s disease
12. Apolipoprotein E and neuronal plasticity following experimental de-afferentation and in Alzheimer’s disease
13. A minimally lipidated form of cell-derived apolipoprotein E exhibits isoform-specific stimulation of neurite outgrowth in the absence of exogenous lipids or lipoproteins
14. Alzheimer disease: Mouse models pave the way for therapeutic opportunities
15. Evidence for normal ageing of the septo-hippocampal cholinergic system in ApoE (-/-) but impaired clearance of axonal degeneration products following injury
16. Apolipoprotein E-containing high density lipoprotein promotes neurite outgrowth and is a ligand for the low density lipoprotein receptor-related protein
17. Two methods for selective silver impregnation of degenerating axons and their synaptic endings in the central nervous system
18. Experimental studies of mechanisms involved in methods demonstrating axonal and terminal degeneration
19. Synaptic reorganisation within the human central nervous system following injury
20. Genetic dissection of Alzheimer’s disease and related dementia’s: Amyloid and its relationship to tau
21. Brain expression of apolipoproteins E, J, and A-I in Alzheimer’s disease
22. A quantitative and immunohistochemical study on apolipoprotein E in brain tissue in Alzheimer’s disease
23. Neuron growth and ApoE
24. Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer’s disease
25. Potential role of ApoE in structural plasticity in the nervous system. Implications for disorders of the central nervous system
26. The role of apolipoprotein E in Alzheimer’s disease, acute brain injury, and cerebrovascular disease: Evidence of common mechanisms and utility of animal models
27. Intraventricular infusion of apolipoprotein E ameliorates acute neuronal damage after global cerebral ischaemia in mice
28. Increased neuronal damage and ApoE immunoreactivity in human apolipoprotein E E4 isoform-specific transgenic mice after global cerebral ischaemia
29. Epidemiological, clinical and neuropathological study of apolipoprotein E genotype in Alzheimer’s disease
30. Effects of age, ethnicity, and head injury on the association between APOE genotypes and Alzheimer’s disease
31. Differential oxidation of apolipoprotein E isoforms and interaction with phospholipids
32. Deposition of apolipoproteins E and J in senile plaques is topographically determined in both Alzheimer’s disease and down’s syndrome brain
33. Apolipoprotein E - Structure, function, and possible roles in Alzheimer’s disease
34. Neurodegeneration in the central nervous system of ApoE deficient mice
35. Patterns of aberrant sprouting in Alzheimer’s disease
36. Alterations in apolipoprotein E expression during ageing and neurodegeneration
37. Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro
38. The inhibitory effect of apolipoprotein E4 on neurite outgrowth is associated with microtubule depolymerisation
39. Amyloid beta-protein, APOE genotype and head injury
40. Role of apolipoprotein E in modulating neurite outgrowth: Potential effect of intracellular apolipoprotein E
41. Apolipoprotein E in animal models of CNS injury and in Alzheimer’s disease
42. Cholesterol synthesis and lipoprotein reuptake during synaptic remodelling in hippocampus in adult rats
43. Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer’s disease
44. Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning
45. Apolipoprotein E, synaptic plasticity and Alzheimer’s disease
46. Role of lipoproteins in the delivery of lipids to axons during axonal regeneration
47. Apolipoprotein E and Alzheimer’s disease. A rapidly expanding field with medical and epidemiological consequences
48. Morphological, biochemical, and genetic support for an apolipoprotein effect on microtubular metabolism
49. A model for susceptibility polymorphism’s for complex diseases: Apolipoprotein E and Alzheimer disease
50. Cis-Acting ApoE tissue pattern of expression elements associated with human pattern of intraneuronal ApoE in transgenic mice
51. Association of apolipoprotein E allele e4 with late-onset familial and sporadic Alzheimer’s disease
52. Human apolipoprotein E accelerates microtubule polymerisation in vitro
53. Apolipoprotein E isoform-specific differences in outcome from focal ischaemia in transgenic mice
54. Astrocytes and microglia respond to estrogen with increased ApoE mRNA in vivo and in vitro
55. Glial fibrillary acidic protein-apolipoprotein E (apoE) transgenic mice: Astrocyte-specific expression and differing biological effects of astrocyte-secreted ApoE3 and apoE4 lipoproteins
56. Apolipoprotein E allele frequency in patients with cognitive defects following cardiopulmonary bypass
57. Association of apolipoprotein E polymorphism with outcome after head injury
58. Modulation of apolipoprotein D and apolipoprotein E expression in rat hippocampus after entorhinal cortex lesion
59. Expression of human apolipoprotein E4 in neurons causes hyperphosphorylation of protein tau in the brains of transgenic mice
60. Human apolipoprotein E isoform-specific differences in neuronal sprouting in organotypic hippocampal culture
61. Specific regional transcription of apolipoprotein E in human brain neurons
62. Regionally specific neuronal expression of human APOE gene in transgenic mice
63. Human apolipoprotein E2, E3 and E4 isoform-specific transgenic mice: Human-like pattern of glial and neuronal immunoreactivity in the central nervous system not observed in wild-type mice